1.
Product Overview
1.1.
Market Definition
1.2.
Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for
Study
1.2.3. Key Market
Segmentations
2.
Research Methodology
2.1.
Objective of the Study
2.2.
Baseline Methodology
2.3.
Key Industry Partners
2.4.
Major Association and Secondary Sources
2.5.
Forecasting Methodology
2.6.
Data Triangulation & Validation
2.7. Assumptions and
Limitations
3.
Executive Summary
3.1.
Overview of the Market
3.2.
Overview of Key Market Segmentations
3.3.
Overview of Key Market Players
3.4.
Overview of Key Regions/Countries
3.5.
Overview of Market Drivers, Challenges, and Trends
4.
Impact of COVID-19 on Global Over the Counter (OTC) Drugs
Market
5.
Global Over the Counter (OTC) Drugs Market Outlook
5.1.
Market Size & Forecast
5.1.1. By Value
5.2.
Market Share & Forecast
5.2.1.
By Product (Cough, Cold & Flu, Vitamins, Mineral,
& Supplements (VMS), Analgesics, Gastrointestinal Products, Dermatology
Products, Others)
5.2.2.
By Dosage Form (Tablets, Capsules, Liquids &
Solutions, Cream/Lotion/Ointments, Others)
5.2.3.
By Region
5.2.4. By Company
(2024)
5.3.
Market Map
6. North America Over
the Counter (OTC) Drugs Market Outlook
6.1.
Market Size & Forecast
6.1.1. By Value
6.2.
Market Share & Forecast
6.2.1. By
Product
6.2.2. By
Dosage Form
6.2.3. By Country
6.3.
North America: Country Analysis
6.3.1. United States Over
the Counter (OTC) Drugs Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Product
6.3.1.2.2.
By Dosage Form
6.3.2. Mexico Over the
Counter (OTC) Drugs Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Product
6.3.2.2.2.
By Dosage Form
6.3.3. Canada Over the
Counter (OTC) Drugs Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Product
6.3.3.2.2.
By Dosage Form
7. Europe Over the
Counter (OTC) Drugs Market Outlook
7.1.
Market Size & Forecast
7.1.1. By Value
7.2.
Market Share & Forecast
7.2.1. By
Product
7.2.2. By Dosage Form
7.2.3. By Country
7.3.
Europe: Country Analysis
7.3.1. France Over the
Counter (OTC) Drugs Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Product
7.3.1.2.2.
By Dosage Form
7.3.2. Germany Over the
Counter (OTC) Drugs Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Product
7.3.2.2.2.
By Dosage Form
7.3.3. United Kingdom Over
the Counter (OTC) Drugs Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Product
7.3.3.2.2.
By Dosage Form
7.3.4. Italy Over the
Counter (OTC) Drugs Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Product
7.3.4.2.2.
By Dosage Form
7.3.5. Spain Over the
Counter (OTC) Drugs Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Product
7.3.5.2.2.
By Dosage Form
8. Asia Pacific Over
the Counter (OTC) Drugs Market Outlook
8.1.
Market Size & Forecast
8.1.1. By Value
8.2.
Market Share & Forecast
8.2.1. By
Product
8.2.2. By
Dosage Form
8.2.3. By Country
8.3.
Asia Pacific: Country Analysis
8.3.1. China Over the
Counter (OTC) Drugs Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Product
8.3.1.2.2.
By Dosage Form
8.3.2. India Over the
Counter (OTC) Drugs Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Product
8.3.2.2.2.
By Dosage Form
8.3.3. South Korea Over the
Counter (OTC) Drugs Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Product
8.3.3.2.2.
By Dosage Form
8.3.4. Japan Over the
Counter (OTC) Drugs Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Product
8.3.4.2.2.
By Dosage Form
8.3.5. Australia Over the
Counter (OTC) Drugs Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Product
8.3.5.2.2.
By Dosage Form
9. South America Over
the Counter (OTC) Drugs Market Outlook
9.1.
Market Size & Forecast
9.1.1. By Value
9.2.
Market Share & Forecast
9.2.1. By
Product
9.2.2. By Dosage Form
9.2.3. By Country
9.3.
South America: Country Analysis
9.3.1. Brazil Over the Counter
(OTC) Drugs Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Product
9.3.1.2.2.
By Dosage Form
9.3.2. Argentina Over the
Counter (OTC) Drugs Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Product
9.3.2.2.2.
By Dosage Form
9.3.3. Colombia Over the
Counter (OTC) Drugs Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Product
9.3.3.2.2.
By Dosage Form
10. Middle East and
Africa Over the Counter (OTC) Drugs Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1. By
Product
10.2.2. By Dosage Form
10.2.3. By Country
10.3.
MEA: Country Analysis
10.3.1. South Africa Over
the Counter (OTC) Drugs Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1.
By Product
10.3.1.2.2.
By Dosage Form
10.3.2. Saudi Arabia Over
the Counter (OTC) Drugs Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1.
By Product
10.3.2.2.2.
By Dosage Form
10.3.3. UAE Over the Counter
(OTC) Drugs Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1.
By Product
10.3.3.2.2.
By Dosage Form
11.
Market Dynamics
11.1.
Drivers
11.2.
Challenges
12.
Market Trends & Developments
12.1.
Merger & Acquisition (If Any)
12.2.
Product Launches (If Any)
12.3.
Recent Developments
13.
Disruptions : Conflicts, Pandemics and Trade Barriers
14.
Global Over the Counter (OTC) Drugs Market: SWOT Analysis
15.
Porters Five Forces Analysis
15.1.
Competition in the Industry
15.2.
Potential of New Entrants
15.3.
Power of Suppliers
15.4.
Power of Customers
15.5.
Threat of Substitute Products
16.
Competitive Landscape
16.1.
Sanofi SA
16.1.1. Business Overview
16.1.2. Company Snapshot
16.1.3. Products &
Services
16.1.4. Financials (As
Reported)
16.1.5. Recent Developments
16.1.6. Key Personnel
Details
16.1.7. SWOT Analysis
16.2.
Pfizer Inc.
16.3.
GlaxoSmithKline plc
16.4.
Perrigo Company plc
16.5.
Reckitt Benckiser Group PLC
16.6.
Takeda Pharmaceutical Company Ltd
16.7.
Boehringer Ingelheim International GmbH
16.8.
Sun Pharmaceutical Industries Ltd.
16.9.
Teva Pharmaceutical Industries Ltd.
16.10.
Glenmark Pharmaceuticals Ltd.
17.
Strategic Recommendations
18.
About Us & Disclaimer